Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
CHANGE IN RATINGS
(ADI - Get Report) upgraded at JP Morgan from Neutral to Overweight. Company is expanding its margins. $49 price target.
(BIG - Get Report) downgraded at Barclays to Equal Weight from Overweight. Upside limited, Barclays said. Price target increased to $42 from $36.
Barnes & Noble
upgraded at Goldman from Sell to Neutral, Goldman Sachs said. $19 price target. Internet business could boost earnings.
downgraded at Jefferies from Buy to Underperform, Jefferies said. $48 price target. Valuation call, as the company could face increased generic competition.
rated new Overweight at Morgan Stanley. $113 price target. Company is a leader in one of the fastest growing areas of health care.
(CRM - Get Report)
upgraded at Jefferies from Hold to Buy, Jefferies said. $165 price target. Company is expanding its market and can drive higher sustainable growth.
(CVC - Get Report)
downgraded at Kaufman from Buy to Hold, Kaufman Bros. said. Valuation call, based on a $37 price target.
upgraded at Barclays to Overweight from Equal Weight. Attractive business model and growth, Barclays said. Maintain $58 price target.
upgraded at Citi to Hold from Sell. Initial storm has passes, but structural concerns remain, Citigroup said. Price target increased a dollar to $36.
(FDO - Get Report)
downgraded at Barclays to Equal Weight from Overweight on limited buyback potential and significant investments in store upgrades, Barclays said. Price target reduced to $46 from $50.
Green Mountain Coffee
upgraded at Keybanc from Hold to Buy, Keybanc said. $55 price target. Company is seeing better brewer sales and should continue to grow through its partnership with SBUX.
rated new Outperform at Cowen and Company. Company is a market leader that trades at a low valuation.
rated new Hold at Jefferies. Coverage of LII was started with a Hold rating, Jefferies said. $55 price target. Macro headwinds could dampen the company's turnaround efforts.
downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Valuation call, based on a $34.50 price target.